1-(tert-Butoxycarbonyl)cyclopropanecarboxylic acid

Catalog No.: 
ACSMZW716
CAS No.: 
1268842-79-0
Molecular Formula: 
C9H14O4
Molecular Weight: 
186.21
1-(tert-Butoxycarbonyl)cyclopropanecarboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$318.00InquiryInquiry
250mg95%$445.00InquiryInquiry
1g95%$885.00InquiryInquiry
5g95%$2531.00InquiryInquiry
10g95%$3744.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(tert-Butoxycarbonyl)cyclopropanecarboxylic acid
IUPAC Name1-(tert-butoxycarbonyl)cyclopropane-1-carboxylic acid
MDL No.MFCD22372629
Molecular FormulaC9H14O4
Molecular Weight186.21
SMILESO=C(C1(C(OC(C)(C)C)=O)CC1)O
InChI KeyFSQXAHDYGFYONQ-UHFFFAOYSA-N
Synonym1-[(tert-butoxy)carbonyl]cyclopropane-1-carboxylic acid;1,1-Cyclopropanedicarboxylic acid, 1-(1,1-dimethylethyl) ester
CAS No.1268842-79-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACSMZW716 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFBPZ072 route compound structure diagram
    ACFBPZ07236809-75-3In Stock
  2. Plus
  3. ACBJYX957 route compound structure diagram
    ACBJYX9573697-66-3In Stock
  4. Then
  5. ACSMZW716 route product structure diagram
    ACSMZW7161268842-79-0
Inquiry

2. ACSMZW716 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSMZW716 route product structure diagram
    ACSMZW7161268842-79-0
Inquiry

3. ACSMZW716 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSMZW716 route product structure diagram
    ACSMZW7161268842-79-0
Inquiry

Comments (0)